RPC Acquires Peracidin® Product Line
PR Newswire•24/08/2026•11:59 ET
0
Whiz Insights
MAPLE GROVE, Minn., Aug. 24, 2026 /PRNewswire/ -- RPC is pleased to announce the successful acquisition of the Peracidin(®) product line from Angelini Pharma, expanding our portfolio of high-quality peroxyacetic/peracetic acid (PAA) sterilants for dialysis, water treatment and life science applications.
This strategic acquisition reinforces our long-term commitment to providing reliable and trusted industry-leading products, exceptional customer support, and uninterrupted supply to healthcare providers and distribution partners worldwide.
Get started
Create a free account to read the full story.